CCL20 and breast carcinoma: Further in agreement with this notion, accumulation of CCL20 has been demonstrated to be able to promote the self-renewal and maintenance of breast cancer stem cells (BCSCs) through p38 mitogen-activated protein kinase (MAPK)-mediated activation of p65 nuclear NF-κB pathway39.